Industry News
Intratumor morphological heterogeneity of cancer is not related to chromosome aberrations
9/30/2015
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations.
Launch of first UK charity dedicated to 36,000 women living with advanced breast cancer
9/30/2015
Second Hope (SecondHope.org.uk), the first UK charity to focus specifically on the needs of the 'forgotten women' living with advanced breast cancer - of which there are currently an estimated...
Scientists pioneer 3-D-printed drug delivering micro-needles
9/30/2015
Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery.
Low-cost blood test good predictor of increased bleeding risk in pediatric trauma patients
9/30/2015
A team of researchers from the Trauma Program at Children's Hospital Los Angeles conclude that an admission hematocrit provides a reliable screening test for identifying pediatric patients who are at...
Aspirin may double survival for cancer patients
9/29/2015
Patients with gastrointestinal cancers who took aspirin after diagnosis were more than twice as likely to survive as those who did not take the drug, a new study finds.
U.S. cervical cancer screening practices show room for improvement
9/29/2015
An analysis published in Annals of Internal Medicine shows that current U.S.
U.S. cervical cancer screening practices show room for improvement
9/29/2015
An analysis published in Annals of Internal Medicine shows that current U.S.
UC Davis researcher advocates ending Medicare coverage of controversial mammography tool
9/29/2015
A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative...
Targeted cancer treatment: new dual strategy halts cell division
9/29/2015
A team of researchers at the MedUni Vienna has confirmed in a recent study its new concept for the targeted treatment of ovarian cancer.
BTG plc company has announced promising data for DC BeadM1™, supporting the efficacy and tolerability of doxorubicin-eluting DC BeadM1™ in the treatment of patients diagnosed with...